Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
News
Oncology
5
Mins
19th December 2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. In South Korea
Israel, December 14, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…
General Healthcare
3
Mins
19th December 2016
Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
USA and Germany, December 15, 2016 – bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene…
Oncology
4
Mins
19th December 2016
First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore
Lugano-Singapore, December 17, 2016 – The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016…
Oncology
1
Mins
19th December 2016
New Autoimmune Mutation Found in Enteritis Pathogenesis
NOVEL immunotherapy has successfully ameliorated the symptoms of autoimmune enteritis following the discovery of a genetic mutation within an immune…
Innovations
1
Mins
19th December 2016
Discovery Could Lead to New Treatments for Parkinson’s Disease
A BIOLOGICAL link has been discovered between the gut microbiome and Parkinson’s disease (PD), potentially leading to the development of new…
General Healthcare
1
Mins
16th December 2016
EMJ Weekly News Round-Up: 12th December
Keeping you up to date with the latest news, summarising a selection of stories from us here at EMJ and from across the web.
Oncology
1
Mins
16th December 2016
Prognostic Models Predict Survival in Cancer Patients Receiving Palliative Care
THE FINDINGS of a new study have identified a group of prognostic models with a good ability to predict survival in cancer patients receiving…
Gastroenterology
5
Mins
16th December 2016
RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn’s Disease
Israel, December 13, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…
Loading posts...
« Previous
1
…
227
228
229
230
231
…
327
Next »